Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bausch + Lomb to purchase ISTA
The transaction, which is subject to regulatory approval and other customary closing conditions, including the approval of ISTA’s shareholders, is expected to close in the second quarter of
The transaction, which is subject to regulatory approval and other customary closing conditions, including the approval of ISTA’s shareholders, is expected to close in the second quarter of
QNASL is delivered as a once-daily, pressurized, HFA-propelled nonaqueous aerosol that is environmentally friendly and offers a built-in dose counter. The company plans to market the nonaqueous or
The Korlym has received FDA approval for patients with endogenous Cushing’s syndrome. PharmaForm is a full-service contract provider of development and manufacturing for the pharmaceutical and biotech industry.
Subsys is a sublingual spray formulation of free fentanyl in a single unit-dose delivery device which disperses a fine mist over a broad sublingual area. The fentanyl sublingual
The two year, $600,000 grant will be used to identify novel highly protective antigens for malaria vaccine development. The work under this grant will build on the research
The new room extenuates the security and accountability of the SEFAR PHARMA-Grade product line that includes fluid bed dryer bags, centrifuge liners, and nutsche filters. The room adheres
Valeant will purchse Natur Produkt for approximately $180m, with an additional $5m in potential future milestones. The transaction is expected to close by mid-2012, subject to certain closing
The engineering optimization and formulation service will leverage the technologies developed with big pharmaceutical companies. The company has developed the spray-dried dispersion (SDD) technology in partnership with Pfizer.
GSK is Genmab’s development and commercial collaborator for the CD20 antibody of atumumab. The dispute concerned two US patents issued to Genentech and City of Hope, which are
The company is currently producing Indium 111 Oxyquinoline for customer evaluation and commercial sale with plans to process additional radioisotopes for medical use. Positron pharmaceuticals vice president Scott